|
Welcome to The International Conference on Biotechnology and Cancer (ICBC) |
| About ICBC Conference |
|
The International Conference on Biotechnology and Cancer (ICBC) is the third international conference organized by the Higher School of Biological Sciences of Oran (ESSBO), December 07-08, 2019 in Oran, Algeria. It is a part of the “Biosciences” conference series initiated by ESSBO a few years ago. Ever since its foundation, “Biosciences" conference has attracted numerous Algerian and international researchers interested in biotechnology advances. This year, “Biosciences” conference will be organized in partnership with the Society for Medical Oncology of Oran (SOMO) and The Thematic Research Agency in Health Science (ATRSS), it will focus on another interesting and hotly debated issue that has raised endless questions over the last decade about Biotechnology and Cancer. In fact, cancer has become a major public health concern in the world. In Algeria, in particular, more than 50,000 new cases appear from year to year. Furthermore, as we move forward through time, we will undoubtedly witness an exponential rise in cancer incidence rates as a result of climatic upheavals and epidemiological transition. As a matter of fact, cancer pathology tends to replace more and more communicable diseases. Given the scale of the disease and its complexity, Algeria has decided to react in order to mitigate the effects on the Algerian population. Thus, the national cancer plan (PNC - 2015 - 2019) has been set up. It has fixed several objectives based on patients, disease, screening, prevention, and data. A broader application of existing cancer control knowledge with an emphasis on disadvantaged groups as well as the integration of new biotechnology approaches would certainly accelerate progress in cancer treatment and prevention. Nowadays, new emerging technologies have greatly contributed to cancer diagnosis and development of new oncotherapy approaches. Biotechnology including immunotechnology, personalized medicine as well as oncogenomics and epigenetics has, definitely, changed the concept of oncotherapy and have revealed a great deal of promising prospects. In effect, we, through ICBC Conference, aim to bring under the same roof researchers and experts using different novel approaches for the same purpose and provide a platform for them to share their work and knowledge in order to shed light on the impact of these new technologies in cancer diagnosis and treatment developments. |
| Target audience |
| Biotechnology and Cancer Conference will be relevant to participants from across a number of fields including cancerology, immunotechnology, genomics, epigenetics and epigenomics, data mining and molecular biology. Notably, young researchers, as well as experts, will have the opportunity to present their work and research advance to the international scientific community. |
| Participation Opportunitiess |
Biosciences Conference Statistics
35 Plenary conferences 
73 Orale communications 
202 Poster communications 
310 Participants |
| Organizing Committee | Scientific Committee |
|
Pr. BABA HAMED Mohammed Bey, ESSB d’Oran, Algeria Pr. SAIDI Djamel, ESSB d’Oran, Algeria Pr. FOUATIH Zoubir, Université Oran 1, Algeria Pr. BOUSAHBA Abdelkader, Université Oran 1, Algeria Pr. BEREKSI REGUIG FAIZA, Chef de service oncologie, Sidi Bel Abbes Dr. RAHLI Fouzia, ESSB d’Oran, Algeria Dr. BOUGHRARA Wefa, ESSB d’Oran, Algeria Dr. MERZOUG Mohamed, ESSB d’Oran, Algeria Dr. FELIDJ Manel, ESSB d’Oran, Algeria Dr. MAHAMMI Fatima Zohra, ESSB d’Oran, Algeria Dr. REDOUANE Dalal, ESSB d’Oran, Algeria Dr. CHOUBANE Slimane, ESSB d’Oran, Algeria Dr. KHELIL Omar, ESSB d’Oran, Algeria Dr. SADDIKIOUI Leila, ESSB d’Oran, Algeria Dr. BENAYAD Sarah, ESSB d’Oran, Algeria Dr MAHDJOUR Soumicha, ESSB d’Oran, Algeria Dr. MAHMOUDI Bahia, ESSB d'Oran, Algeria Dr. BEREKSI Samia, ESSB d’Oran, Algeria Dr. YAKOUBI Fatima, ESSB d’Oran, Algeria Dr. BENYETTOU Imene, ESSB d’Oran, Algeria Dr. BOUKHARI BENAHMED DAIDJ Nabila, ESSB d’Oran, Algeria Dr. ILIAS-CHERIF Wassila, ESSB d’Oran, Algeria Dr. BOUKADOUM Ali, ESSB d’Oran, Algeria M. AGGAB Tayeb, ESSB d’Oran, Algeria Mme SAAD AZZOUZ Karima, ESSB d’Oran, Algeria Mme YACOUBI Lamia, ESSB d’Oran, Algeria M. SOUAK Abdelkader, ESSB d’Oran, Algeria M. MAHIDA Rachid, ESSB d’Oran, Algeria Chair of the Organizing Committee Pr. BABA HAMED Mohammed Bey, ESSB d’Oran, Algeria |
Pr. SAIDI Djamel, ESSB d’Oran, Algeria Pr. BABA HAMED Mohammed Bey, ESSB d’Oran, Algeria Pr. FOUATIH Zoubir, Université Oran 1, Algeria Pr. BITAM Idir, ESSAIA, Alger. Pr. BOUSAHBA Abdelkader, Université Oran 1, Algeria Pr. MERGHOUB Taha, New York City, USA Dr. CHENNA Ahmad, San Francisco, USA Dr. HIHI Abdelmadjid, Clinatec, Grenoble, France Dr. BOUDJELAL Mohamed, Riyadh. KSA Pr. BEREKSI REGUIG FAIZA, Chef de service oncologie, Sidi Bel Abbes Pr. ABERKANE Meryem, USTO, Oran, Algeria Pr. MESLI Farida, Université Oran 1, Algeria Dr. BOUGHRARA Wefa, ESSB d’Oran, Algeria Dr. MERZOUG Mohamed, ESSB d’Oran, Algeria Dr. RAHLI Fouzia, ESSB d’Oran, Algeria Dr. FELIDJ Manel, ESSB d’Oran, Algeria Dr. MAHAMMI Fatima Zohra, ESSB d’Oran, Algeria Dr. BOUDERBALA Hadjer, ESSB d’Oran, Algeria Dr. CHOUBANE Slimane, ESSB d’Oran, Algeria Dr. KHELIL Omar, ESSB d’Oran, Algeria Dr. SADDIKIOUI Leila, ESSB d’Oran, Algeria Dr. BENAYAD Sarah, ESSB d’Oran, Algeria Dr. MAHMOUDI Bahia, ESSB d'Oran, Algeria Dr. BEREKSI Samia, ESSB d’Oran, Algeria Dr. YAKOUBI Fatima, ESSB d’Oran, Algeria Dr. BENYETTOU Imene, ESSB d’Oran, Algeria Dr MAHDJOUR Soumicha, ESSB d’Oran, Algeria Dr. ILIAS-CHERIF Wassila, ESSB d’Oran, Algeria Dr. LADLI Meriem, ESSB d’Oran, Algeria Dr. MOGHTIT Fatima Zohra, CU Ain Témouchent, Algeria Chair of the Scientific Committee Pr. SAIDI Djamel, ESSB d’Oran, Algeria |
| Conference Poster |
